This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ishizaka, N. Articles by Griendling, K. K. Search for Related Content PubMed PubMed Citation Articles by Ishizaka, N. Articles by Griendling, K. K. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB LOSARTAN POTASSIUM

(Hypertension. 1997;29:790-795.)
© 1997 American Heart Association, Inc.

Articles

Heme Oxygenase-1 Is Regulated by Angiotensin II in Rat Vascular Smooth Muscle Cells

Nobukazu Ishizaka; Kathy K. Griendling

the Department of Medicine, Division of Cardiology, Emory University School of Medicine, Atlanta, Ga.

Correspondence to Nobukazu Ishizaka, Emory University Division of Cardiology, 319 Woodruff Memorial Bldg, 1639 Pierce Dr, Atlanta, GA 30322. E-mail nishizaka@emory.edu

Recently, heme oxygenase-1 (HO-1) has been shown to be present in vascular smooth muscle cells. In the present study, we examined the effect of angiotensin II (Ang II) on HO-1 in rat vascular smooth muscle cells. After treatment with 100 nmol/L Ang II, HO-1 mRNA levels were decreased, with a nadir at 2 hours (39±9% of the control level, P<.01). This downregulation was completely blocked by the Ang II type 1 receptor antagonist losartan. Western blot analysis showed that HO-1 protein is also significantly downregulated, with a nadir at 4 hours (52±6% of the control level, P<.01). Heme oxygenase activity was also significantly decreased at 4 hours (control, 0.35±0.86 nmol bilirubin/mg per hour; Ang II, 0.10±0.06). This downregulation was observed in serum-starved cells to a similar extent as in serum-supplemented cells. Inhibitors of protein kinase C, lipoxygenase, cyclooxygenase, cytochrome P450 monooxygenase, and phospholipase A₂ did not block this downregulation. However, this effect was not observed in the absence of calcium and presence of EGTA (2 mmol/L). Furthermore, a 2-hour incubation with calcium ionophore or arginine vasopressin decreased HO-1 mRNA levels, suggesting that an increase of intracellular calcium mediates the downregulation. In conclusion, Ang II decreases HO-1 mRNA in a calcium-dependent manner in vascular smooth muscle cells, which may provide a novel mechanism for the modulation of vascular tone and oxidative stress.

Key Words: angiotensin • muscle, smooth, vascular • antioxidants

This article has been cited by other articles:

				G. Alba, R. El Bekay, P. Chacon, M. E. Reyes, E. Ramos, J. Olivan, J. Jimenez, J. M. Lopez, J. Martin-Nieto, E. Pintado, et al. Heme oxygenase-1 expression is down-regulated by angiotensin II and under hypertension in human neutrophils J. Leukoc. Biol., August 1, 2008; 84(2): 397 - 405. [Abstract] [Full Text] [PDF]

				N. G. Abraham and A. Kappas Pharmacological and Clinical Aspects of Heme Oxygenase Pharmacol. Rev., March 1, 2008; 60(1): 79 - 127. [Abstract] [Full Text] [PDF]

				M. J. Martin, T. Tanos, A. B. Garcia, D. Martin, J. S. Gutkind, O. A. Coso, and M. J. Marinissen The G{alpha}12/13 Family of Heterotrimeric G Proteins and the Small GTPase RhoA Link the Kaposi Sarcoma-associated Herpes Virus G Protein-coupled Receptor to Heme Oxygenase-1 Expression and Tumorigenesis J. Biol. Chem., November 23, 2007; 282(47): 34510 - 34524. [Abstract] [Full Text] [PDF]

				S. W. Ryter, J. Alam, and A. M. K. Choi Heme Oxygenase-1/Carbon Monoxide: From Basic Science to Therapeutic Applications Physiol Rev, April 1, 2006; 86(2): 583 - 650. [Abstract] [Full Text] [PDF]

				L. Wu and R. Wang Carbon Monoxide: Endogenous Production, Physiological Functions, and Pharmacological Applications Pharmacol. Rev., December 1, 2005; 57(4): 585 - 630. [Abstract] [Full Text] [PDF]

				L. Yang, S. Quan, A. Nasjletti, M. Laniado-Schwartzman, and N. G. Abraham Heme Oxygenase-1 Gene Expression Modulates Angiotensin II-Induced Increase in Blood Pressure Hypertension, June 1, 2004; 43(6): 1221 - 1226. [Abstract] [Full Text] [PDF]

				F. A. D. T. G. Wagener, H.-D. Volk, D. Willis, N. G. Abraham, M. P. Soares, G. J. Adema, and C. G. Figdor Different Faces of the Heme-Heme Oxygenase System in Inflammation Pharmacol. Rev., September 1, 2003; 55(3): 551 - 571. [Abstract] [Full Text] [PDF]

				M. T. Unlap, E. Bates, C. Williams, P. Komlosi, I. Williams, G. Kovacs, B. Siroky, and P. D. Bell Na+/Ca2+ Exchanger: Target for Oxidative Stress in Salt-Sensitive Hypertension Hypertension, September 1, 2003; 42(3): 363 - 368. [Abstract] [Full Text] [PDF]

				F. Mazza, A. Goodman, G. Lombardo, A. Vanella, and N. G. Abraham Heme Oxygenase-1 Gene Expression Attenuates Angiotensin II-Mediated DNA Damage in Endothelial Cells Experimental Biology and Medicine, May 1, 2003; 228(5): 576 - 583. [Abstract] [Full Text] [PDF]

				T. L. Pallone, Z. Zhang, and K. Rhinehart Physiology of the renal medullary microcirculation Am J Physiol Renal Physiol, February 1, 2003; 284(2): F253 - F266. [Abstract] [Full Text] [PDF]

				N. Ishizaka, T. Aizawa, M. Ohno, S.-i. Usui, I. Mori, S.-S. Tang, J. R. Ingelfinger, S. Kimura, and R. Nagai Regulation and Localization of HSP70 and HSP25 in the Kidney of Rats Undergoing Long-Term Administration of Angiotensin II Hypertension, January 1, 2002; 39(1): 122 - 128. [Abstract] [Full Text] [PDF]

				N. Ishizaka, T. Aizawa, I. Mori, J.-I. Taguchi, Y. Yazaki, R. Nagai, and M. Ohno Heme oxygenase-1 is upregulated in the rat heart in response to chronic administration of angiotensin II Am J Physiol Heart Circ Physiol, August 1, 2000; 279(2): H672 - H678. [Abstract] [Full Text] [PDF]

				W. Gonzalez, V. Fontaine, M. E. Pueyo, N. Laquay, D. Messika-Zeitoun, M. Philippe, J.-F. Arnal, M.-P. Jacob, and J.-B. Michel Molecular Plasticity of Vascular Wall During NG-Nitro-L-Arginine Methyl Ester-Induced Hypertension : Modulation of Proinflammatory Signals Hypertension, July 1, 2000; 36(1): 103 - 109. [Abstract] [Full Text] [PDF]

				T. Aizawa, N. Ishizaka, J.-i. Taguchi, R. Nagai, I. Mori, S.-S. Tang, J. R. Ingelfinger, and M. Ohno Heme Oxygenase-1 Is Upregulated in the Kidney of Angiotensin II-Induced Hypertensive Rats : Possible Role in Renoprotection Hypertension, March 1, 2000; 35(3): 800 - 806. [Abstract] [Full Text] [PDF]

				C. M. Terry, J. A. Clikeman, J. R. Hoidal, and K. S. Callahan TNF-alpha and IL-1alpha induce heme oxygenase-1 via protein kinase C, Ca2+, and phospholipase A2 in endothelial cells Am J Physiol Heart Circ Physiol, May 1, 1999; 276(5): H1493 - H1501. [Abstract] [Full Text] [PDF]

				R. C.M. Siow, H. Sato, and G. E. Mann Heme oxygenase-carbon monoxide signalling pathway in atherosclerosis: anti-atherogenic actions of bilirubin and carbon monoxide? Cardiovasc Res, February 1, 1999; 41(2): 385 - 394. [Abstract] [Full Text] [PDF]

				I. J. Benjamin and D. R. McMillan Stress (Heat Shock) Proteins : Molecular Chaperones in Cardiovascular Biology and Disease Circ. Res., July 27, 1998; 83(2): 117 - 132. [Abstract] [Full Text] [PDF]

				G. W. De Keulenaer, D. C. Chappell, N. Ishizaka, R. M. Nerem, R. W. Alexander, and K. K. Griendling Oscillatory and Steady Laminar Shear Stress Differentially Affect Human Endothelial Redox State : Role of a Superoxide-Producing NADH Oxidase Circ. Res., June 1, 1998; 82(10): 1094 - 1101. [Abstract] [Full Text] [PDF]